Nautilus Biotechnology, Inc.·4

Aug 22, 7:40 PM ET

Mowry Anna 4

4 · Nautilus Biotechnology, Inc. · Filed Aug 22, 2022

Insider Transaction Report

Form 4
Period: 2022-08-19
Mowry Anna
CFO and Treasurer
Transactions
  • Purchase

    Common Stock

    2022-08-19$2.30/sh+17,500$40,21956,750 total
Footnotes (1)
  • [F1]Represents the weighted average share price of an aggregate total of 17,500 shares purchased in the price range of $2.29 to $2.30 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    wf-form4_166121152658656.xmlPrimary

    FORM 4